22nd Century Group Inc (NASDAQ:XXII)
| 2.45 Delayed Data As of 4:00pm ET |  +0.10 / +4.26%Today’s Change | 1.54 Today|||52-Week Range 6.07 | +11.36% Year-to-Date |
Latest XXII News | Press Releases
No recent news for 22nd Century Group Inc.
Today’s Trading
| Previous close | 2.35 |
| Today’s open | 2.43 |
| Day’s range | 2.38 - 2.56 |
| Volume | 127,098 |
| Average volume (3 months) | 1,569,672 |
| Market cap | $403.6M |
Data as of 4:00pm ET, 12/07/2021
Growth & Valuation
| Earnings growth (last year) | +32.94% |
| Earnings growth (this year) | -28.57% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +8.82% |
| P/E ratio | NM |
| Price/Sales | 10.86 |
| Price/Book | 7.82 |
Competitors
Data as of 4:00pm ET, 12/07/2021
Financials
| Next reporting date | March 9, 2022 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $28.1M |
| Annual profit (last year) | -$19.7M |
| Net profit margin | -70.12% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Buffalo, New York |
Forecasts
